Pathogenesis of gout: Exploring more therapeutic target

Area of Science:

• Immunology
• Metabolic Diseases
• Rheumatology

Background:

• Gout is a chronic metabolic and immune disorder characterized by monosodium urate crystal deposition.
• Gout flares manifest as acute inflammatory arthritis, potentially leading to joint damage and organ dysfunction.
• Current treatments for gout flares, primarily anti-inflammatory analgesics, have limitations and side effects.

Purpose of the Study:

• To explore the multifaceted pathogenesis of gout.
• To identify novel therapeutic targets for gout flare management.
• To provide insights into safer and more effective treatment alternatives.

Main Methods:

• Review of scientific literature on gout pathogenesis.
• Analysis of gout mechanisms from four key perspectives: signaling pathways, inflammatory factors, intestinal flora, and programmed cell death.
• Focus on identifying emerging therapeutic targets.

Main Results:

• Gout pathogenesis is complex, involving intricate signaling cascades.
• Inflammatory factors play a crucial role in gout flare development.
• Alterations in intestinal flora and programmed cell death pathways are implicated in gout.

Conclusions:

• Understanding gout pathogenesis from multiple angles is essential for developing new therapies.
• Targeting signaling pathways, inflammation, gut microbiota, and cell death offers promising avenues for gout treatment.
• Further research into these areas can lead to improved patient outcomes for gout flare.